GWPHARM - Trademark Details
Status: 604 - Abandoned - After Inter-Partes Decision
Serial Number
79154002
Word Mark
GWPHARM
Status
604 - Abandoned - After Inter-Partes Decision
Status Date
2015-10-13
Filing Date
2014-06-05
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2015-02-17
Attorney Name
Law Office Assigned Location Code
N10
Employee Name
FAIRBANKS, RONALD L
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; veterinary preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, spasticity, convulsions, seizures, epilepsy, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, obesity, obesity associated with diabetes; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes
Pseudo Mark
GW PHARMACEUTICALS
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
8 - Abandoned
Class Status Date
2015-10-13
Primary Code
005
Correspondences
Name
MICHELLE L VISSER
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Prior Registration | 3910241 |
International Registrations
International Registration Number
1220677
International Registration Date
2014-06-05
International Publication Date
2014-10-30
International Renewal Date
2024-06-05
Auto Protection Date
2016-04-30
International Status
001 - Request for extension of protection established
International Status Date
2014-10-30
Priority Claimed In
True
Priority Claimed Date
2014-01-21
First Refusal In
True
Trademark Events
Event Date | Event Description |
2014-10-30 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2014-11-04 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2014-11-04 | ASSIGNED TO EXAMINER |
2014-11-04 | NON-FINAL ACTION WRITTEN |
2014-11-05 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2014-11-06 | REFUSAL PROCESSED BY MPU |
2014-11-06 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2014-11-08 | APPLICATION FILING RECEIPT MAILED |
2014-11-21 | REFUSAL PROCESSED BY IB |
2014-11-22 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2014-11-22 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2014-11-22 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2014-11-25 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2014-11-25 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2014-12-21 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2015-01-12 | ASSIGNED TO LIE |
2015-01-12 | ASSIGNED TO LIE |
2015-01-14 | ASSIGNED TO LIE |
2015-01-14 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2015-01-28 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2015-01-28 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2015-01-28 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2015-02-14 | NOTIFICATION PROCESSED BY IB |
2015-02-17 | PUBLISHED FOR OPPOSITION |
2015-02-17 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2015-03-19 | OPPOSITION PAPERS RECEIVED AT TTAB |
2015-03-20 | OPPOSITION NOTICE (IB REFUSAL) CREATED |
2015-03-20 | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB |
2015-03-23 | OPPOSITION INSTITUTED NO. 999999 |
2015-04-24 | REFUSAL PROCESSED BY IB |
2015-06-19 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
2015-10-13 | OPPOSITION SUSTAINED NO. 999999 |
2015-10-13 | OPPOSITION TERMINATED NO. 999999 |
2015-10-13 | ABANDONMENT - AFTER INTER PARTES DECISION |
2015-10-13 | ABANDONMENT NOTICE MAILED - INTER PARTES DECISION |
2016-10-13 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2016-10-13 | FINAL DISPOSITION NOTICE SENT TO IB |
2016-10-28 | FINAL DECISION TRANSACTION PROCESSED BY IB |
2017-12-21 | NEW REPRESENTATIVE AT IB RECEIVED |
2021-11-20 | NEW REPRESENTATIVE AT IB RECEIVED |